Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Careers Booklet

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Sci. STKE, 28 September 1999
Vol. 1999, Issue 1, p. tw12
[DOI: 10.1126/stke.1999.1.tw12]

EDITORS' CHOICE

Suppressing cancer and autoimmunity?

Abstract: Mutations of the Pten tumor suppressor gene, which encodes a phosphatase, occur in both sporadic and inherited human cancers. Di Cristofano et al. show that mice carrying heterozygous mutations in Pten develop lymphomas and suffer from autoimmune disease in a manner similar to that seen in mice with inactivating mutations in Fas or Fas ligand. T and B cells from the Pten heterozygous mice were impaired in Fas-mediated apoptosis. These results implicate Pten in the Fas response and suggest that it may play a role as a suppressor of autoimmunity as well as cancer.

Di Cristofano, A., Kotsi, P., Peng, Y.F., Cordon-Cardo, C., Elkon, K.B., and Pandolfi, P.P. (1999) Impaired Fas response and autoimmunity in Pten +/- mice. Science 285: 2122-2125. [Abstract] [Full Text]

Citation: Suppressing cancer and autoimmunity? Sci. STKE 1999, tw12 (1999).

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (pre-2008: Science's STKE. ISSN 1525-8882)